Richard Castledine is Head of Drug Substance Operations at Quotient Sciences, based out of our Alnwick, UK location. In his current role, Richard is responsible for the Analytical Development, Process Research and Development, Solid State Chemistry, and Drug Substance Production teams.

Richard has 15 years of experience in the pharmaceutical and contract development industries. After completing a PhD in synthetic organic chemistry at the University of Nottingham, he worked briefly as a medicinal chemist before moving into process chemistry. He has led process development of over 25 programs at different stages of development ranging from pre-clinical and Phase I to process validation.